With nearly two decades of experience in molecular diagnostics, biotechnology, and life sciences, Andy Moye is a leader in the fields of pathology, oncology, genomics, and precision medicine.
As CEO of Paige, Andy is driving the company’s mission to advance cancer detection, patient care, and treatment through cutting-edge AI technology. Paige aims to transform cancer diagnostics by harnessing the power of tissue-based AI, not only through industry-leading AI products but also by collaborating with labs worldwide to improve patient care.
Under Andy’s leadership, Paige successfully launched Paige Prostate Detect, the first AI-based pathology product authorized by the FDA for cancer detection in prostate biopsies. Andy’s focus extends to the development of disruptive biomarker AI algorithms, empowering pathologists to access previously inaccessible information.
What are the core values on which the organization is built and what is the mission of the organization?
Paige is guided by being A.D.E.P.T – accountable, disruptive, execution-focused, patient-centric, and trusting. We work every day toward creating an environment where our employees feel supported so that they can create the best possible products for clinicians.
Our mission as an organization is to transform the world of cancer care through these AI tools – We frame this for most of the clinical users by reminding them that we already have techniques like IHC, PCR, NGS, and ISH, and now we have AI. AI is another tool at pathologists’ fingertips that can help them get to the right answer with greater efficiency and confidence.
Tools like the Paige Prostate Suite and Paige Breast Suite can ensure pathologists catch even the smallest and most complex cancers and are able to grade and quantify cancer in a more standardized way. For example, using Paige Breast Lymph Node, pathologists might catch a metastatic lesion that would have otherwise been missed because it was too small. In fact, in one recent study, Paige’s Breast Lymph Node improved pathologist sensitivity by 12%. This directly impacts treatment, which of course is the most important impact we can have.
What are some of the biggest challenges that you face when using AI in cancer research and treatment, and how are you addressing these challenges?
The biggest challenge in the adoption of AI is really just change management. But AI tools are just that – tools that work together with pathologists to support a final diagnosis and streamline workflows. And like any new technology that gets adopted in healthcare, AI and digital pathology must address all facets of the quadruple aim – that is to reduce costs, improve clinical outcomes, and enhance physician and patient experience. We believe AI directly impacts all four areas.
So, to overcome this challenge, we educate pathologists, clinicians, and laboratory professionals about the benefits of AI and digital pathology. We enable these pathologists by providing powerful information at their fingertips, so they can make the best treatment decisions for patients. We may see a whole new generation of pathologists that will come into the field who are more like informatic pathologists. They will understand how to use the technology and how to curate the information they’re getting from AI and all the different algorithms. When pathologists see a whole-slide image on a viewer and all of the information they can see digitally, they’re blown away by how much easier and more efficiently it allows them to work.
Read the Full Interview @ https://ai-techpark.com/aitech-interview-with-andy-moye/
Article source: https://article-realm.com/article/Business/44988-AITech-Interview-with-Andy-Moye-CEO-at-Paige.html
Reviews
Comments
Most Recent Articles
- Mar 27, 2024 Talc Market Is Likely to Experience a Tremendous Growth by 2031 by mansi jain
- Mar 27, 2024 Socks Market Is Likely to Experience a Tremendous Growth by 2031 by mansi jain
- Mar 27, 2024 Non-Woven Tape Market is Expected to Register a Considerable Growth by 2028 by Matt Easterlin
- Mar 27, 2024 Membrane Separation Technology Market to Signify Strong Growth by 2024-2031 by mansi jain
- Mar 27, 2024 Indian DiCalcium Phosphate Market to Signify Strong Growth by 2024-2031 by mansi jain
Most Viewed Articles
- 715 hits Thin Wall Packaging Market to Witness Growth Acceleration by 2029 by faraz pathan
- 662 hits Air Traffic Control Equipment Market to Witness Robust Expansion by 2029 by faraz pathan
- 578 hits Air Traffic Control Equipment (ATC) Market Analysis, Size, Current Scenario and Future Prospects by faraz pathan
- 550 hits HDPE Blow Molding and Injection Molding Containers Market 2029 by faraz pathan
- 316 hits Route Optimization and Planning Software Market Value Projected to Expand by 2029 by faraz pathan
Popular Articles
In today’s competitive world, one must be knowledgeable about the latest online business that works effectively through seo services....
76865 Views
Are you caught in between seo companies introduced by a friend, researched by you, or advertised by a particular site? If that is the...
31906 Views
Walmart is being sued by a customer alleging racial discrimination. The customer who has filed a lawsuit against the retailer claims that it...
12026 Views
If you have an idea for a new product, you can start by performing a patent search. This will help you decide whether your idea could become the...
10195 Views
Statistics
Members | |
---|---|
Members: | 13874 |
Publishing | |
---|---|
Articles: | 58,269 |
Categories: | 202 |
Online | |
---|---|
Active Users: | 347 |
Members: | 5 |
Guests: | 342 |
Bots: | 2111 |
Visits last 24h (live): | 3669 |
Visits last 24h (bots): | 18306 |